NCT00679510View on ClinicalTrials.gov

Rosuvastatin in Rheumatoid Arthritis (RORA)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

rosuvastatin

tablet 10 mgs once daily

DRUG

placebo

placebo

Trial Locations (1)

Unknown

University of Dundee, Dundee

All Listed Sponsors
lead

University of Dundee

OTHER

NCT00679510 - Rosuvastatin in Rheumatoid Arthritis (RORA) | Biotech Hunter | Biotech Hunter